Reported number of people receiving antiretroviral therapy in Indonesia
Indonesia: Reported number of people receiving antiretroviral therapy was 266,681 in 2025. ◆ Volatile
Reported number of people receiving antiretroviral therapy in Indonesia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Indonesia recorded 266,681 for reported number of people receiving antiretroviral therapy in 2025. That is the highest value across all 26 years on record.
That represents a change of up 15.3% on the previous year and up 322.0% over ten years.
Over the whole period, reported number of people receiving antiretroviral therapy in Indonesia peaked at 266,681 in 2025 and was at its lowest, 4, in 2000.
That places Indonesia 17th out of 143 countries with data for 2025, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Reported number of people receiving antiretroviral therapy in Indonesia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 4 | — |
| 2001 | 8 | +100.0% |
| 2002 | 12 | +50.0% |
| 2003 | 16 | +33.3% |
| 2004 | 20 | +25.0% |
| 2005 | 605 | +2925.0% |
| 2006 | 4,904 | +710.6% |
| 2007 | 7,471 | +52.3% |
| 2008 | 10,733 | +43.7% |
| 2009 | 16,085 | +49.9% |
| 2010 | 20,090 | +24.9% |
| 2011 | 24,861 | +23.7% |
| 2012 | 31,195 | +25.5% |
| 2013 | 37,798 | +21.2% |
| 2014 | 50,304 | +33.1% |
| 2015 | 63,199 | +25.6% |
| 2016 | 77,748 | +23.0% |
| 2017 | 91,024 | +17.1% |
| 2018 | 107,837 | +18.5% |
| 2019 | 126,614 | +17.4% |
| 2020 | 141,643 | +11.9% |
| 2021 | 151,947 | +7.3% |
| 2022 | 164,612 | +8.3% |
| 2023 | 177,277 | +7.7% |
| 2024 | 231,247 | +30.4% |
| 2025 | 266,681 | +15.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3,986 | 4 | 16,085 | 10 |
| 2010s | 63,067 | 20,090 | 126,614 | 10 |
| 2020s | 188,901 | 141,643 | 266,681 | 6 |
Countries ranked near Indonesia
More health data for Indonesia
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4924 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,286 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,463 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 50 (2025)
- Population ages 00-04, female, annual growth rate -0.5792 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0376 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5519 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is reported number of people receiving antiretroviral therapy in Indonesia?
- Reported number of people receiving antiretroviral therapy in Indonesia was 266,681 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest reported number of people receiving antiretroviral therapy recorded in Indonesia?
- The highest recorded value was 266,681 in 2025.
- What is the lowest reported number of people receiving antiretroviral therapy recorded in Indonesia?
- The lowest recorded value was 4 in 2000.
- How does Indonesia rank for reported number of people receiving antiretroviral therapy?
- Indonesia ranks 17th out of 143 countries with data for 2025.
- Is reported number of people receiving antiretroviral therapy rising or falling in Indonesia?
- Over the last ten years it is up 322.0%. The long-run trend across the full record is volatile.
- Where does this Indonesia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Reported number of people receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).